Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
Clinical trial NCT02784171 · COMPLETED
Trial details
- NCT number
- NCT02784171
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-11
- Primary completion
- 2024-10-11
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.